If you’re lucky enough to live to 80, you’ll take up to a billion breaths…
Subscribe to Updates
Get health & wellness insight updates.
Author: Emma Yasinski
I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.
When Pat (now 71) was in her 40s, her vaginal dryness became so severe that the vaginal tissue would flare with even a gentle wipe. She’d been exposed to a drug called DES (diethylstilbestrol) when she was in utero, which caused myriad health issues as she grew up, and was likely behind the dryness. For her, coconut oil made a huge difference. “If only I had known I was not alone with this personal issue,” she says. Vaginal dryness is likely more common than you think. It can affect women of any age, but is especially prevalent among those who…
In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the few safer options to treat pain in pregnancy, since Advil (ibuprofen) and opioids are considered riskier. They pointed out that, in some cases, a woman’s condition (fever and pain, for example) could be worse for…
A new chemotherapy drug promises to treat some patients with pediatric acute lymphoblastic leukemia (ALL) who have been unable to take the other two other chemo medicines because one can cause allergic reactions and the other is frequently in short supply. This summer, the Food and Drug Administration (FDA) fast-tracked the approval of Rylaze, a newer version of the chemo drug Erwinaze to treat ALL, made by Jazz Pharmaceuticals, which was previously distributed Erwinaze. The agency approved Rylaze based on an ongoing Phase 2/3 trial of about 102 patients, with an average age of 10. The rare disease ALL affects…
May 26 Update: Only 62.6% of patients taking methotrexate, an immunosuppressant drug used in some cancer patients, mounted an effective antibody response to Pfizer’s vaccine, according to a study Stephanie, a Stage 4 endometrial cancer patient who has undergone both chemotherapy and immunotherapy since 2019, has been especially cautious throughout the pandemic. “We know how deadly this virus is, especially for older people and those who are immunocompromised,” like herself, she says. “And if not lethal, the complications for Covid-19 survivors are severe.” The jury is still out on how exactly the COVID-19 vaccine affects cancer patients. Yet some studies point…
If you’ve recently started experiencing anxiety that’s disrupting your life, it could also be a side effect of a medicine you take.
Anxiety is a normal reaction to stress, but for some people, it can become overwhelming and debilitating. People with types of anxiety disorder feel apprehensive and uneasy, and it’s common for them to experience negative thoughts that make them more fearful. According to the National Institute of Mental Health (NIMH): More than 40 million American adults ages 18 and older have an anxiety disorder, and nearly one-third of adults will experience an anxiety disorder at some point in their life. Anxiety disorders frequently co-occur with depressive disorders or substance abuse. Most people with an anxiety disorder also have depression. Most…
MedShadow is introducing a weekly news feature called Quick Hits: brief summaries of recent news items related to our mission. Light therapy is under investigation as a way to ease the fatigue and depression that people with cancer often suffer from. Researchers at the Icahn School of Medicine at Mount Sinai in New York City conducted a series of clinical trials examining whether regular exposure to bright white light from a light box could improve their symptoms. In the latest trial, cancer patients exposed to the bright white light saw their depression symptoms subside much more than a control group…
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
Symptoms & Concerns
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward